AST SpaceMobile (ASTS) delivered earnings and revenue surprises of -115.79% and -77.55%, respectively, for the quarter ended June 2025. Do the numbers...

AST SpaceMobile faces earnings miss and macro headwinds, yet its manufacturing footprint expansion and telecom partnerships keep growth hopes alive.

CLRO posts a wider Q2 loss on revenue decline, rising costs and supply issues as it pursues an asset sale to address ongoing risks.

CLRO posts a wider Q2 loss on revenue decline, rising costs and supply issues as it pursues an asset sale to address ongoing risks.

INTZ posts fifth straight quarter of revenue growth in Q2 2025, fueled by DoD contracts and rising adoption of its Shield cybersecurity suite.

INTZ posts fifth straight quarter of revenue growth in Q2 2025, fueled by DoD contracts and rising adoption of its Shield cybersecurity suite.

CENX posts second-quarter loss and misses estimates despite higher aluminum shipments and improved regional premiums.

CENX posts second-quarter loss and misses estimates despite higher aluminum shipments and improved regional premiums.

EXK posts a Q2 loss despite a 46% rise in revenues, as higher costs and weaker gold output weigh on results.

Summit Therapeutics posts wider-than-expected second-quarter loss as ivonescimab trials advance in multiple lung cancer settings.